Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Navann Ty is an analyst at Exane BNP Paribas. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/16/2023 | RVNC | Buy Now | Revance Therapeutics | — | — | Navann Ty69% | → $20 | Upgrade | Underperform → Neutral | Get Alert |
| 05/30/2023 | KVUE | Buy Now | Kenvue | $23.53 | 19% | Navann Ty69% | → $28 | Initiates | → Neutral | Get Alert |
| 03/22/2022 | ALKS | Buy Now | Alkermes | $33.03 | -21.28% | Navann Ty69% | $22 → $26 | Maintains | Neutral | Get Alert |
| 03/10/2022 | VTRS | Buy Now | Viatris | $9.58 | 14.87% | Navann Ty69% | $16 → $11 | Maintains | Neutral | Get Alert |
| 03/09/2022 | ENDP | Buy Now | Endo International | — | — | Navann Ty69% | $11 → $6 | Maintains | Buy | Get Alert |
| 12/20/2021 | ZTS | Buy Now | Zoetis | $163.75 | 41.68% | Navann Ty69% | $184 → $232 | Maintains | Neutral | Get Alert |
| 12/01/2021 | ALKS | Buy Now | Alkermes | $33.03 | -33.39% | Navann Ty69% | → $22 | Initiates | → Neutral | Get Alert |
| 10/05/2021 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 40.78% | Navann Ty69% | → $200 | Initiates | → Buy | Get Alert |
| 08/05/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | $117 → $121 | Maintains | Buy | Get Alert |
| 07/23/2021 | OGN | Buy Now | Organon | $15.87 | 120.54% | Navann Ty69% | → $35 | Initiates | → Buy | Get Alert |
| 07/22/2021 | OGN | Buy Now | Organon | $15.87 | 120.54% | Navann Ty69% | → $35 | Initiates | → Buy | Get Alert |
| 06/15/2021 | VTRS | Buy Now | Viatris | $9.58 | 67.08% | Navann Ty69% | → $16 | Initiates | → Neutral | Get Alert |
| 05/12/2021 | ZTS | Buy Now | Zoetis | $163.75 | 12.37% | Navann Ty69% | $175 → $184 | Maintains | Neutral | Get Alert |
| 03/18/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | → $120 | Maintains | Buy | Get Alert |
| 08/27/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | → $112 | Initiates | → Buy | Get Alert |
| 08/10/2020 | ZTS | Buy Now | Zoetis | $163.75 | -2.29% | Navann Ty69% | $146 → $160 | Maintains | Neutral | Get Alert |
| 07/30/2020 | ZTS | Buy Now | Zoetis | $163.75 | -10.84% | Navann Ty69% | $131 → $146 | Maintains | Neutral | Get Alert |
| 05/01/2019 | ALKS | Buy Now | Alkermes | $33.03 | -0.09% | Navann Ty69% | $62 → $33 | Downgrade | Buy → Neutral | Get Alert |
| 05/01/2019 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | $21 → $32 | Upgrade | Neutral → Buy | Get Alert |
| 05/01/2019 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | — | Upgrade | Neutral → Buy | Get Alert |
| 07/10/2018 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 44.3% | Navann Ty69% | $162 → $205 | Maintains | Buy | Get Alert |
| 06/27/2018 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2018 | ALKS | Buy Now | Alkermes | $33.03 | — | Navann Ty69% | — | Upgrade | Neutral → Buy | Get Alert |
| 11/28/2016 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | — | Reinstates | Neutral → Buy | Get Alert |
| 09/27/2016 | ALKS | Buy Now | Alkermes | $33.03 | 60.46% | Navann Ty69% | $44 → $53 | Maintains | Neutral | Get Alert |
| 08/09/2016 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | $18 → $21 | Maintains | Neutral | Get Alert |
| 04/25/2016 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | $21 → $18 | Maintains | Neutral | Get Alert |
| 01/06/2016 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | — | Assumes | → Neutral | Get Alert |
| 03/27/2015 | ALKS | Buy Now | Alkermes | $33.03 | 114.96% | Navann Ty69% | $83 → $71 | Downgrade | Buy → Neutral | Get Alert |
| 03/02/2015 | HZNP | Buy Now | Horizon Therapeutics | — | — | Navann Ty69% | $19 → $23 | Maintains | Buy | Get Alert |
| 02/25/2015 | ALKS | Buy Now | Alkermes | $33.03 | 151.29% | Navann Ty69% | $85 → $83 | Maintains | Buy | Get Alert |
| 01/14/2015 | ALKS | Buy Now | Alkermes | $33.03 | 157.34% | Navann Ty69% | $72 → $85 | Maintains | Buy | Get Alert |
| 12/17/2014 | ALKS | Buy Now | Alkermes | $33.03 | 117.98% | Navann Ty69% | $60 → $72 | Maintains | Buy | Get Alert |
| 11/05/2014 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 42.18% | Navann Ty69% | $165 → $202 | Maintains | Buy | Get Alert |
| 05/09/2014 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 16.14% | Navann Ty69% | $195 → $165 | Maintains | Buy | Get Alert |
| 03/12/2013 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | -47.21% | Navann Ty69% | $70 → $75 | Maintains | Buy | Get Alert |
| 01/15/2013 | ALKS | Buy Now | Alkermes | $33.03 | -9.17% | Navann Ty69% | $27 → $30 | Maintains | Buy | Get Alert |
| 11/27/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | -50.73% | Navann Ty69% | → $70 | Initiates | → Buy | Get Alert |
| 04/10/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | -57.77% | Navann Ty69% | → $60 | Initiates | → Buy | Get Alert |
